Mother-to-child transmission of HIV-2 infection from 1986 to 2007 in the ANRS French perinatal cohort EPF-CO1

Clinical Infectious Diseases

Volumn 51, Issue 7, 2010, Pages 833-843

  Burgard, M ^a   Jasseron, Carine ^e   Matheron, S ^b,c   Damond, F ^b   Hamrene, K ^e   Blanche, S ^a,c   Faye, A ^c,d   Rouzioux, C ^a,c   Warszawski, J ^e,f   Mandelbrot, L ^c,e,g   Decaux, N ^h   Douadi, Y ^h   Gondry, J ^h   Li Thiao Te, V ^h   Schmit, J L ^h   Fournie A ⁱ   Allisy, C ^j   Brault, D ^j   Questiaux, E ^k   Zakaria, A ^k   Goldenstein, C ^k   Pincemaille, O ^l   Bonnal, F ^m   Cayla, C ^m   Hernandorena, X ^m   Estavoyer, J M ⁿ   Maillet, R ⁿ   Bentata, M ^o   Benoist, L ^p   Bolie, S ^p   Bonier, N ^p   Lachassine, E ^p   Rodrigues, A ^p   Douard, D ^q   Roux, D ^q   Schaeffer, V ^q   Beucher, G ^r   Brouard, J ^r   Goubin, P ^r   Elenga, N ^s   Carpentier, B ^t   Duval Arnould, M ^t   Kingue Ekollo, C ^t   Garrait, V ^u   Lemerle, S ^u   Pichon, C ^u   Richier, C ^u   Touboul, C ^u   Bornarel, D ^v   Chambrin, V ^v   Clech, L ^v   Foix L'Helias L ^v   Labrune, P ^v   Schoen, H ^v   Crenn Hebert, C ^g   Floch Tudal, C ^g   Mazy, F ^g   Hery, E ^g   Meier, C ^g   Martha, S ^w   Reynaud, I ^w   Allouche, C ^x   Toure K ^x   Chevojon, P ^y   Devidas, A ^y   Granier, M ^y   Marchand, C ^y   May, A ^y   Nguyen, R ^y   Turpault, I ^y,ag   Alissa, K ^z   Routier, C ^z   Hatchuel, Y ^aa   William, C ^aa   Chalvon Demersay, A ^ab   Froguel, E ^ab   Gourdel, B ^ab   Lanty, C ^ab   Aubry, O ^ac   Brossier, J P ^ac   Esnault, J L ^ac   Leautez, S ^ac   Perre P ^ac   Suaud, I ^ac   Chamouilli, J M ^ad   Hentgen, V ^ae   Messaoudi, F ^ae   Fourcade, C ^e   Fridman, S ^e   Peretti, D ^e   D'Angelo, S ^af   Hammou, Y ^af   Mazingue, F ^af   Bailly Salin, P ^ag   Seaume, H ^ag   Bertrand, Y ^ah   Brochier, C ^ah   Cotte, L ^ah   more..

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b BICHAT HOSPITAL   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d HÔPITAL ROBERT DEBRÉ   (France)

^e BICÊTRE HOSPITAL   (France)

^f UNIVERSITÉ PARIS SACLAY   (France)

^g HÔPITAL LOUIS MOURIER   (France)

^h AMIENS UNIVERSITY HOSPITAL   (France)

ⁱ Hopital d'Angers   (France)

^j CENTRE HOSPITALIER VICTOR DUPOUY   (France)

^k Centre Hospitalier Robert Ballanger CHRB   (France)

^l Hôpital de Bastia   (France)

^m Renal Unit Hôpital de la Côte Basque   (France)

ⁿ HÔPITAL SAINT JACQUES   (France)

^o AVICENNE HOSPITAL   (France)

^p HÔPITAL JEAN VERDIER   (France)

^q HÔPITAL PELLEGRIN   (France)

^r CHU Clemenceau   (France)

^s Hôpital André Rosemon   (France)

^t Hôpital de Creil   (France)

^u CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

^v HÔPITAL ANTOINE BÉCLÈRE   (France)

^w Medical University of Dijon   (France)

^x Hôpital Intercommunal   (France)

^y Centre Hospitalier (CH) Sud Francilien   (France)

^z Hôpital de Fontainebleau   (France)

^aa Hôpital Victor Fouche   (France)

^ab Centre hospitalier de Lagny Marne la Vallee   (France)

^ac Hôpital Les Oudairies   (France)

^ad Hôpital de la Seyne Sur Mer   (France)

^ae CENTRE HOSPITALIER DE VERSAILLES   (France)

^af LILLE UNIVERSITY HOSPITAL   (France)

^ag Hopital de Longjumeau   (France)

^ah HÔTEL DIEU   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EFAVIRENZ; LAMIVUDINE; ZIDOVUDINE;

ADULT; AFRICA; ARTICLE; BREAST FEEDING; CD4 LYMPHOCYTE COUNT; DELIVERY; FEMALE; GESTATIONAL AGE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS 2 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFANT; MAJOR CLINICAL STUDY; MONOTHERAPY; MOTHER TO CHILD TRANSMISSION; PATIENT COMPLIANCE; PERINATAL PERIOD; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; VIRUS LOAD; VIRUS TRANSMISSION;

EID: 77957833771     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/656284     Document Type: Article

References (47)

1. Matheron S, Pueyo S, Damond F, et al. Factors associated with clinical progression in HIV-2 infected-patients: the French ANRS cohort. AIDS 2003; 17:2593-601. (Pubitemid 38402337)
2. Cazein F, Lot F, Pillonel J, et al. HIV and AIDS surveillance in France, 2006. Bull Epidemiol Hebd 2007; 46-47:386-93.
3. Marlink R, Kanki P, Thior I, et al. Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science 1994; 265:1587-90.
4. De Cock KM, Adjorlolo G, Ekpini E, et al. Epidemiology and transmission of HIV-2. Why there is no HIV-2 pandemic. JAMA 1993; 270: 2083-6.
5. O'Donovan D, Ariyoshi K, Milligan P, et al. Maternal plasma viral RNA levels determine marked differences in mother-to-child transmission rates of HIV-1 and HIV-2 in The Gambia. MRC/Gambia Government/ University College London Medical School Working Group on Mother-Child Transmission of HIV. AIDS 2000; 14:441-8. (Pubitemid 30182442)
6. Adjorlolo-Johnson G, De Cock KM, Ekpini E, et al. Prospective comparison of mother-to-child transmission of HIV-1 and HIV-2 in Abidjan, Ivory Coast. JAMA 1994; 272:462-6.
7. EPF. Comparison of vertical human immunodeficiency virus type 2 and human immunodeficiency virus type 1 transmission in the French prospective cohort. The HIV Infection in Newborns French Collaborative Study Group. Pediatr Infect Dis J 1994; 13:502-6.
8. Andreasson PA, Dias F, Naucler A, Andersson S, Biberfeld G. A prospective study of vertical transmission of HIV-2 in Bissau, Guinea- Bissau. AIDS 1993; 7:989-93. (Pubitemid 23239674)
9. Matheron S, Courpotin C, Simon F, et al. Vertical transmission of HIV-2. Lancet 1990; 335:1103-4.
10. De Cock KM, Fowler MG, Mercier E, et al. Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice. JAMA 2000; 283:1175-82. (Pubitemid 30126606)
11. European Collaborative Study. Children born to women with HIV-1 infection: natural history and risk of transmission. Lancet 1991; 337: 253-60.
12. Lepage P, Van de Perre P, Msellati P, et al. Mother-to-child transmission of human immunodeficiency virus type 1 (HIV-1) and its determinants: a cohort study in Kigali, Rwanda. Am J Epidemiol 1993; 137:589-99. (Pubitemid 23118084)
13. Lallemant M, Le Coeur S, Samba L, et al. Mother-to-child transmission of HIV-1 in Congo, central Africa. Congolese Research Group on Mother-to-Child Transmission of HIV. AIDS 1994; 8:1451-6. (Pubitemid 24296803)
14. Warszawski J, Tubiana R, Le Chenadec J, et al. Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort. AIDS 2008; 22:289-99.
15. Cooper ER, Charurat M, Mofenson L, et al. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr 2002; 29:484-94.
16. Mandelbrot L, Landreau-Mascaro A, Rekacewicz C, et al. Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1. JAMA 2001; 285:2083-93.
17. European Collaborative Study. Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. Clin Infect Dis 2005; 40:458-65.
18. Townsend CL, Cortina-Borja M, Peckham CS, de Ruiter A, Lyall H, Tookey PA. Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006. AIDS 2008; 22:973-81.
19. Newell ML, Huang S, Fiore S, et al. Characteristics and management of HIV-1-infected pregnant women enrolled in a randomised trial: differences between Europe and the USA. BMC Infect Dis 2007; 7:60.
20. Boer K, England K, Godfried MH, Thorne C. Mode of delivery in HIV-infected pregnant women and prevention of mother-to-child transmission: changing practices in Western Europe. HIV Med 2010; 11:368-78.
21. Von Linstow ML, Rosenfeldt V, Lebech AM, et al. Prevention of mother-to-child transmission of HIV in Denmark, 1994-2008. HIV Med 2010; 11:448-56.
22. Centers for Disease Control and Prevention. Achievements in public health. Reduction in perinatal transmission of HIV infection - United States, 1985-2005. MMWR Morb Mortal Wkly Rep 2006; 55:592-7.
23. Yeni P. Prise en charge médicale des personnes infectées par le VIH. Paris: Flammarion, 2008.
24. Centers for Disease Control and Prevention. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992; 41: 1-19.
25. Damond F, Collin G, Descamps D, et al. Improved sensitivity of human immunodeficiency virus type 2 subtype B plasma viral load assay. J Clin Microbiol 2005; 43:4234-6.
26. Damond F, Benard A, Ruelle J, et al. Quality control assessment of human immunodeficiency virus type 2 (HIV-2) viral load quantification assays: results from an international collaboration on HIV-2 infection in 2006. J Clin Microbiol 2008; 46:2088-91.
27. Rouet F, Ekouevi DK, Inwoley A, et al. Field evaluation of a rapid human immunodeficiency virus (HIV) serial serologic testing algorithm for diagnosis and differentiation of HIV type 1 (HIV-1), HIV-2, and dual HIV-1-HIV-2 infections in West African pregnant women. J Clin Microbiol 2004; 42:4147-53.
28. Damond F, Loussert-Ajaka I, Apetrei C, et al. Highly sensitive method for amplification of human immunodeficiency virus type 2 DNA. J Clin Microbiol 1998; 36:809-11.
29. Barin F, Cazein F, Lot F, et al. Prevalence of HIV-2 and HIV-1 group O infections among new HIV diagnoses in France: 2003-2006. AIDS 2007; 21:2351-3.
30. Faye A, Burgard M, Crosnier H, Retbi JM, Blanche S. Human immunodeficiency virus type 2 infection in children. J Pediatr 1997; 130: 994-7.
31. Mayaux MJ, Dussaix E, Isopet J, et al. Maternal virus load during pregnancy and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohort studies. SEROGEST Cohort Group. J Infect Dis 1997; 175:172-5.
32. Sperling RS, Shapiro DE, Coombs RW, et al. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clin ical Trials Group Protocol 076 Study Group. N Engl J Med 1996; 335: 1621-9.
33. Lallemant M, Jourdain G, Le Coeur S, et al. Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand. N Engl J Med 2004; 351:217-28.
34. Cao Y, Krogstad P, Korber BT, et al. Maternal HIV-1 viral load and vertical transmission of infection: the Ariel Project for the prevention of HIV transmission from mother to infant. Nat Med 1997; 3:549-52.
35. Dickover RE, Garratty EM, Herman SA, et al. Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission: effect of maternal zidovudine treatment on viral load. JAMA 1996; 275:599-605.
36. Garcia PM, Kalish LA, Pitt J, et al. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group. N Engl J Med 1999; 341:394-402.
37. European Collaborative Study. Maternal viral load and vertical transmission of HIV-1: an important factor but not the only one. AIDS 1999; 13:1377-85.
38. Mofenson LM, Lambert JS, Stiehm ER, et al. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team. N Engl J Med 1999; 341:385-93.
39. Simon F, Matheron S, Tamalet C, et al. Cellular and plasma viral load in patients infected with HIV-2. AIDS 1993; 7:1411-7.
40. Popper SJ, Sarr AD, Travers KU, et al. Lower human immunodeficiency virus (HIV) type 2 viral load reflects the difference in pathogenicity of HIV-1 and HIV-2. J Infect Dis 1999; 180:1116-21.
41. Ariyoshi K, Jaffar S, Alabi AS, et al. Plasma RNA viral load predicts the rate of CD4 T cell decline and death in HIV-2-infected patients in West Africa. AIDS 2000; 14:339-44.
42. Drylewicz J, Matheron S, Lazaro E, et al. Comparison of viro-immunological marker changes between HIV-1 and HIV-2-infected patients in France. AIDS 2008; 22:457-68.
43. Andersson S, Norrgren H, da Silva Z, et al. Plasma viral load in HIV-1 and HIV-2 singly and dually infected individuals in Guinea-Bissau, West Africa: significantly lower plasma virus set point in HIV-2 infection than in HIV-1 infection. Arch Intern Med 2000; 160:3286-93.
44. Matheron S. Editorial comment: HIV-2 infection: a call for controlled trials. AIDS 2008; 22:2073-4.
45. Sankale JL, Mboup S, Essex ME, Kanki PJ. Genetic characterization of viral quasispecies in blood and cervical secretions of HIV-1- and HIV-2-infected women. AIDS Res Hum Retroviruses 1998; 14:1473-81.
46. Desbois D, Roquebert B, Peytavin G, et al. In vitro phenotypic susceptibility of human immunodeficiency virus type 2 clinical isolates to protease inhibitors. Antimicrob Agents Chemother 2008; 52:1545-8.
47. Cooper DA. HIV therapy advances: early antiretroviral therapy. AIDS 1994; 8(Suppl 3):S9-14.